PLIANT THERAPEUTICS, INC. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pliant Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Pliant Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $500K, unchanged year-over-year.
  • Pliant Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $2.1M, a 15.5% increase year-over-year.
  • Pliant Therapeutics, Inc. annual Depreciation for 2023 was $1.84M, a 0.99% increase from 2022.
  • Pliant Therapeutics, Inc. annual Depreciation for 2022 was $1.82M, a 18.8% increase from 2021.
  • Pliant Therapeutics, Inc. annual Depreciation for 2021 was $1.54M, a 17.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.84M +$18K +0.99% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $1.82M +$288K +18.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $1.54M +$225K +17.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $1.31M +$197K +17.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $1.11M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.